BIASIN, MARA
 Distribuzione geografica
Continente #
EU - Europa 11.121
NA - Nord America 7.706
AS - Asia 5.510
SA - Sud America 628
AF - Africa 130
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.174
Nazione #
US - Stati Uniti d'America 7.412
GB - Regno Unito 3.760
IT - Italia 2.157
CN - Cina 2.090
DE - Germania 1.803
SG - Singapore 1.244
SE - Svezia 836
HK - Hong Kong 624
RU - Federazione Russa 471
BR - Brasile 444
IN - India 426
FR - Francia 366
NL - Olanda 356
IE - Irlanda 317
TR - Turchia 254
CA - Canada 241
FI - Finlandia 221
UA - Ucraina 193
ID - Indonesia 188
KR - Corea 188
ES - Italia 107
VN - Vietnam 103
BE - Belgio 92
PL - Polonia 86
DK - Danimarca 83
JP - Giappone 83
CO - Colombia 76
AU - Australia 69
CH - Svizzera 62
EU - Europa 57
AT - Austria 44
TW - Taiwan 41
MX - Messico 36
CZ - Repubblica Ceca 32
RO - Romania 28
ZA - Sudafrica 28
IR - Iran 26
AR - Argentina 24
BD - Bangladesh 24
EC - Ecuador 24
CL - Cile 22
GR - Grecia 21
IQ - Iraq 19
KE - Kenya 19
NO - Norvegia 19
SA - Arabia Saudita 19
TH - Thailandia 19
PH - Filippine 17
PK - Pakistan 17
LB - Libano 16
PT - Portogallo 15
UZ - Uzbekistan 15
VE - Venezuela 15
EG - Egitto 14
SC - Seychelles 14
AE - Emirati Arabi Uniti 13
PE - Perù 13
MY - Malesia 12
ET - Etiopia 10
JO - Giordania 10
MA - Marocco 10
IL - Israele 9
DZ - Algeria 8
HU - Ungheria 8
BG - Bulgaria 7
QA - Qatar 7
LT - Lituania 6
NG - Nigeria 6
LK - Sri Lanka 5
NP - Nepal 5
OM - Oman 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
EE - Estonia 4
KG - Kirghizistan 4
KW - Kuwait 4
RS - Serbia 4
TN - Tunisia 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AZ - Azerbaigian 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BO - Bolivia 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MD - Moldavia 3
MZ - Mozambico 3
NZ - Nuova Zelanda 3
A1 - Anonimo 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
Totale 25.199
Città #
Southend 3.452
Chandler 840
Singapore 796
Milan 776
Hanover 635
Hong Kong 563
Fairfield 456
Seattle 452
Ashburn 396
Beijing 360
Dublin 312
Wilmington 305
Princeton 300
Ann Arbor 292
Council Bluffs 253
Frankfurt am Main 249
Woodbridge 235
Houston 215
Redwood City 184
Boardman 181
Cambridge 168
Jakarta 152
Santa Clara 152
Dearborn 142
Nanjing 141
Toronto 128
Des Moines 126
Shanghai 126
Munich 117
Mountain View 116
Jacksonville 114
Rome 110
Bengaluru 109
The Dalles 106
Berlin 105
Guangzhou 93
Columbus 91
Redmond 87
Jinan 79
Helsinki 74
Los Angeles 74
Phoenix 73
Brussels 68
Shenyang 67
New York 62
Istanbul 61
Bodio Lomnago 54
Cangzhou 52
Sakarya 52
Sunnyvale 52
Changsha 50
São Paulo 49
Warsaw 46
Bogotá 45
Pisa 43
Serra 43
Margão 42
Nuremberg 42
Hangzhou 40
Tokyo 40
Andover 39
Fuzhou 37
Somerville 37
Nanchang 36
San Diego 36
Turin 36
Wuhan 36
Falls Church 35
London 33
Ottawa 32
Dong Ket 31
Turku 31
Zhengzhou 31
Grafing 29
Kiez 29
Hebei 28
Boston 27
Taipei 27
Tianjin 27
Eitensheim 26
Fremont 26
Mumbai 26
Silver Spring 26
Cassano Magnago 25
Vienna 25
Chicago 24
Haikou 24
Segrate 24
Bitonto 23
Medford 23
Seoul 23
Bühl 22
Lappeenranta 22
Tappahannock 22
Athens 21
Jiaxing 21
Kent 19
Paris 19
Roxbury 19
San Francisco 19
Totale 15.739
Nome #
Occupational HIV infection in a research laboratory with unknown mode of transmission : a case report 784
ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior 569
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders 485
Sterol metabolism modulates susceptibility to HIV-1 Infection 404
The interleukin 21 (IL 21)/ microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection 370
A Glycomimetic Compound Inhibits DC-SIGN Mediated HIV Infection in Cellular and Cervical Explant Models 338
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial 333
Analysis of SARS-CoV-2 vertical transmission during pregnancy 330
Transcriptomic analysis of HCN-2 cells suggests connection among oxidative stress, senescence, and neuron death after SARS-CoV-2 infection 295
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection 285
Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) is released in the secretome of activated MDMs and reduces in vitro HIV-1 infection 275
Genetic and epigenetic regulation of natural resistance to HIV-1 infection: new approaches to unveil the HESN secret 275
A functional variant in ERAP1 predisposes to multiple sclerosis 267
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G : a possible role in the resistance to HIV of HIV-exposed seronegative individuals 259
TLR3 mutations in adult patients with Herpes Simplex virus and Varicella Zoster virus encephalitis 259
Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity 256
A regulatory polymorphism in HAVCR2 modulates susceptibility to HIV-1 infection 251
Evolutionary analysis identifies an MX2 haplotype associated with natural resistance to HIV-1 infection 247
Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters 245
Modulation of Human Immunodeficiency Virus (HIV)-Specific Immune Response by Using Efavirenz, Nelfinavir, and Stavudine in a Rescue Therapy Regimen for HIV-Infected, Drug-Experienced Patients 240
Evaluation of the effect of protective genetic variants on cART success in HIV-1-infected patients 235
Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines 231
UV-C irradiation is highly effective in inactivating SARS-CoV-2 replication 229
Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia 218
The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery 218
Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis 215
Pseudo-mannosylated compounds inhibit DC-SIGN mediated HIV infection by competitive inhibition and by interfering with DC-SIGN signal 213
{SARS}-{CoV}-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis 212
Immunological characterization of whole tumour lysate-loaded dendritic cells for cancer immunotherapy 211
The pathophysiological role of estrogens in the initial stages of pregnancy: molecular mechanisms and clinical implications for pregnancy outcome from the periconceptional period to end of the first trimester 206
Immunomodulating activity of Pidotimod in children with Down syndrome 204
Thiazolides elicit anti-viral innate immunity and reduce HIV replication 202
A role for mucosal immunity in resistance to HIV infection 197
Transfusion of red blood cells from an HIV-RNA-positive/anti-HIV-negative donor without HIV infection in the recipient 195
Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals 192
A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection? 191
A 175 million year history of T cell regulatory molecules reveals widespread selection, with adaptive evolution of disease alleles 190
Variants in the CYP7B1 gene region do not affect natural resistance to HIV-1 infection 190
High Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals 189
Plasma and PBMC miRNA profile in sexually HIV-1 exposed seronegative individuals 188
An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases 187
Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha 186
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals 180
Ancient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors 178
Emergency Lung Transplantation after {COVID}-19: Immunopathological Insights on Two Affected Patients 177
Anti-inflammatory effects of immunostimulation in patients with covid-19 pneumonia 176
Type 1 and type 2 cytokines in HIV infection: a possible role in apoptosis and disease progression 173
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infection 173
HPV in sperm is efficiently removed by washing: A suitable approach for assisted reproduction 169
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression 168
Population genetics of IFIH1: ancient population structure, local selection, and implications for susceptibility to type 1 diabetes 167
A pseudo-glycodendrimer Inhibits DC-SIGN-Mediated HIV Trans-Infection and Interferes with DC-SIGN Signal 167
An evolutionary analysis of antigen processing and presentation across different timescales reveals pervasive selection 166
Immune activation is present in HIV-1 Exposed Seronegative Individuals (HESN) and is indipendent from microbial translocation 166
Plasma and PBMC miRNA Profile in sexually HIV-1 exposed seronegative individuals 166
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response 166
AIDS in Africa 165
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response 165
TLR activation pathways in HIV-1-exposed seronegative individuals 160
Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy 158
Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin 158
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection 155
Thiazolides elicit anti-viral innate immunity and drastically reduce HIV replication in vitro 155
Peripheral blood lymphocyte proliferation specific for HTLV-Tax peptides in enzyme-linked immunosorbent assay-negative HTLV DNA-positive blood donors 152
IL-4 and CXCR4 upregulation in HIV-infected and uninfected individuals from Maharashtra-Mumbai 152
Genetic correlates of protection against HIV infection : the ally within 152
Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes 152
Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or -treated individuals 150
Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents 148
Evoluzione delle cellule e genetica degli organelli cellulari 147
Inflammasome and Th17 activation in HIV+ immunological nonresponders 147
Inflammasome and Pyroptosis are Involved in The Lack of Immune Response During cART 144
Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons 143
Plasma and PBMC miRNA profile in sexually HIV- exposed seronegative individuals 143
MiRNA profiling in plasma and placenta of SARS-CoV-2-infected pregnant women 141
A 6-Amino-Acid Insertion/Deletion Polymorphism in TIM1 Confers Protections Against HIV1 140
APPARATUS AND METHOD FOR SAMPLING AND DETECTING A PATHOGEN IN AIR 139
Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection 139
Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering 139
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals 139
Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naive patients with undetectable viraemia 138
Immunological characterization of hiv and sars-cov-2 coinfected young individuals 138
Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infection. 137
Active and precursor forms of Vitamin D reduce HIV-1 infection in vitro 136
A pseudo-glycodendrimer inhibits DC-sign-mediated HIV trans-infection and interferes with DC-sign signal 135
Crohn's disease loci are common targets of protozoa-driven selection 133
Analysing the role of STAT3 in HIV-1 infection 133
Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms 133
Antiretroviral therapy initiation alters the redox system of asymptomatic HIV-Infected individuals 132
ERAPs Reduce In Vitro HIV Infection by Activating Innate Immune Response 132
Immunologic correlates of protection in exposed-seronegative individuals 130
Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein 129
Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection 128
Serum HIV neutralizing activity and IgA in exposed seronegative partners (ESN) of HIV seropositive individuals 128
The genetic basis of resistance to HIV infection and disease progression 128
Long-term balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene 127
Alterazione della produzione di citochine di tipo 1 e 2 in condizioni fisiologiche e patologiche 127
Higher Levels of Peripheral Th17 T Cd4+ Cells are Associated With Immunological Non-Response in Hiv-Infected Patients Undereffective Art 126
Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature 126
UV and violet light can Neutralize SARS-CoV-2 Infectivity 126
Totale 19.863
Categoria #
all - tutte 80.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.783 133 288 210 131 196 250 213 191 300 204 403 264
2021/20223.582 285 222 204 503 294 222 241 285 405 295 154 472
2022/20233.145 363 367 277 283 313 573 94 216 331 63 171 94
2023/20242.531 113 194 182 195 530 251 196 141 71 148 184 326
2024/20255.454 239 463 133 455 419 278 365 561 303 585 551 1.102
2025/2026252 252 0 0 0 0 0 0 0 0 0 0 0
Totale 26.329